Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/1993
08/10/1993CA1321140C Use of mullerian inhibiting substance as a contraceptive agent
08/07/1993WO1993015754A1 Hepatic growth factor receptor
08/07/1993CA2129423A1 Hepatic growth factor receptor
08/06/1993CA2088804A1 Tgf-beta induced gene and protein
08/05/1993WO1993015405A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor
08/05/1993WO1993015216A1 Novel heterodimeric nuclear receptors proteins, genes encoding same, and usage thereof
08/05/1993WO1993015210A1 Monomeric and dimeric antibody-fragment fusion proteins
08/05/1993WO1993015205A2 Synthetic haemophilus influenzae conjugate vaccine
08/05/1993WO1993015202A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins
08/05/1993WO1993015201A1 Novel protein tyrosine kinases
08/05/1993WO1993015199A1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides
08/05/1993WO1993015193A1 Mammalian expression systems for hcv proteins
08/05/1993WO1993015192A1 Insecticidally effective peptides
08/05/1993WO1993015117A1 Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents
08/05/1993WO1993015114A1 Large, latent complexes of tgf-beta2 and tgf-beta3
08/05/1993WO1993015111A1 A dna sequence and encoded polypeptide useful in the diagnosis of hepatitis disease
08/05/1993WO1993015050A1 Immunological analogs for captan
08/05/1993WO1993014786A1 Composition and method to prevent conception or to cause sterility in animals
08/05/1993WO1993014782A1 Methods of controlling the proliferation of macrophages
08/05/1993WO1993014776A1 Icam-related protein
08/05/1993WO1993014750A2 Amino acids useful as inhibitors of the advanced glycosylation of proteins
08/05/1993WO1993009234A3 Suppressor and progenitor cells
08/05/1993WO1993006866A3 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
08/05/1993CA2129350A1 Immunological analogs for captan
08/05/1993CA2128879A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins
08/05/1993CA2128722A1 Novel protein tyrosine kinases
08/05/1993CA2128700A1 Carcinoma associated antigen (sk1) and monoclonal antibodies against sk1, methods of producing these antibodies and use therefor
08/05/1993CA2107363A1 A dna sequence and encoded polypeptide useful in the diagnosis of hepatitis disease
08/05/1993CA2106382A1 Heterodimeric nuclear receptors proteins, genes encoding same, and usage thereof
08/04/1993EP0553287A1 Cytokine-induced marker for inflammatory response
08/04/1993EP0553244A1 Targeted immunostimulation with bispecific reagents
08/04/1993EP0553198A1 Regulation of immunoglobulin production by interleukin-9
08/04/1993EP0553117A1 Genetically engineered coccidiosis vaccine
08/04/1993EP0553113A1 Adhesion receptors for pathogenic or opportunistic microorganisms
08/04/1993EP0553077A1 Monoclonal antibodies to cyclodiene insecticides and method for detecting the same
08/04/1993EP0417193B1 Freeze-dried formulation for antibody products
08/04/1993EP0203093B1 Monoclonal antibodies against alveolar surfactant protein
08/04/1993EP0201511B1 Alpha-amidation enzyme
08/04/1993EP0198026B1 Monoclonal antibodies to cyclosporings
08/04/1993CN1074936A Insecticidally effective peptides
08/04/1993CN1074844A Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents
08/03/1993US5233025 Hybridoma cell line for producing monoclonal antibody
08/03/1993US5233024 Anti-idiotypic monoclonal antibodies for mucoid pseudomonas aeruginosa, their preparation and use
08/03/1993US5232834 Anti-human sperm antibody, and its production and use
08/03/1993US5232832 Antibody reactive to hamster immunoglobulins and assay using same
08/03/1993CA1320906C Interleukin-2 induced antineoplastic peptide
08/01/1993WO1993014775A1 Monoclonal antibody pd41 and antigen associated with prostate adenocarcinomas
08/01/1993CA2106487A1 Monoclonal antibody pd41 and antigen associated with prostate adenocarcinomas
08/01/1993CA2088396A1 Pyridine derivatives
07/1993
07/28/1993EP0552850A1 Cloning and expression of HTLV-III DNA
07/28/1993EP0552297A1 Hepatitis c virus antibody
07/28/1993EP0552296A1 Mouse monoclonal antibodies
07/28/1993EP0552266A1 Preparation of chimaeric antibodies using the recombinant pcr strategy
07/28/1993EP0552142A1 T cell receptor peptides as therapeutics for autoimmune and malignant disease
07/28/1993CN1074684A Thioether conjugates
07/28/1993CA2107097A1 Icam-related protein
07/27/1993US5231168 Malaria antigen
07/27/1993US5231026 DNA encoding murine-human chimeric antibodies specific for antigenic epitopes of IgE present on the extracellular segment of the membrane domain of membrane-bound IgE
07/27/1993US5231025 Coagulation
07/27/1993US5231024 Hybridoma cells
07/27/1993US5231012 Genes and proteins
07/27/1993US5231009 Cdnas coding for members of the carcinoembryonic antigen family
07/27/1993US5231003 Monoclonal antibodies specific for toxin b of clostridium difficile
07/27/1993US5231002 Synthetic SCM-active cancer recognition peptides
07/27/1993US5231001 Trk tyrosine kinase receptor is the physiological receptor for nerve growth factor
07/27/1993US5231000 Monoclonal antibodies for Alzheimer*s disease
07/27/1993US5230999 Antiischemic
07/27/1993US5230997 Methods of detecting the presence of human herpesvirus-7 infection
07/27/1993US5230888 Polio virus and DNA sequence codes
07/27/1993US5230887 Autoimmune disease
07/27/1993CA1320718C Chromatographic material
07/27/1993CA1320689C Monoclonal antibody specific for human basal cell surface antigen
07/27/1993CA1320688C Affinity column and process for detection of low molecular weight toxic substances
07/27/1993CA1320682C Diagnostic probes for detecting elastase modified antithrombin and methods of treatment
07/22/1993WO1993014406A1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis
07/22/1993WO1993014220A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1
07/22/1993WO1993014219A1 Marek's disease virus recombinant poxvirus vaccine
07/22/1993WO1993014209A1 Vaccines based on streptokinase
07/22/1993WO1993014208A2 Hepatitis e virus vaccine and method
07/22/1993WO1993014206A2 Synthetic peptides for a rubella vaccine
07/22/1993WO1993014202A1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
07/22/1993WO1993014201A1 Dna encoding a human 5-ht1f receptor and uses thereof
07/22/1993WO1993014125A1 Novel lymphocytic antigen, corresponding antibody and applications thereof
07/22/1993WO1993014117A1 Peptides of the casein macropeptide, antibodies directed against said peptides, and applications
07/22/1993WO1993014116A1 Hepatitis e virus peptide antigens and antibodies
07/22/1993WO1993014115A1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock
07/22/1993WO1993014109A1 Mammalian adipogenic factors
07/22/1993WO1993014098A1 Antigen recognized by patients with antibody associated lambert-eaton myasthenic syndrome (lems), dna encoding same and uses thereof
07/22/1993WO1993013805A1 Cytotoxic drug therapy
07/22/1993WO1993013798A1 Treatment for asthma
07/22/1993WO1993013785A1 Induced tolerance to xenografts
07/22/1993WO1993013784A1 Platelet transfusion
07/22/1993WO1993013775A1 Diaminopyridine compounds for the inhibition of protein glycosylation
07/22/1993WO1993013772A1 Methods for using histamine derivatives as immunomodulators and in immunotherapeutics
07/22/1993WO1993010239A3 Hepatitis-c virus testing
07/22/1993WO1993007262A3 Purified chitin deacetylase
07/22/1993WO1993006852A3 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein
07/22/1993WO1993002693A3 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
07/22/1993DE4201461A1 Agent for selective hyperthermia and chemotherapy of tumours - consists of ferromagnetic particles encapsulated in matrix which is not phagocyted and is able to couple with antitumour agent
07/22/1993CA2128331A1 Methods for using histamine derivatives as immunomodulators and in immunotherapeutics